NZM2 Stock Overview
Produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Novonesis A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 52.68 |
| 52 Week High | DKK 65.02 |
| 52 Week Low | DKK 46.32 |
| Beta | 0.54 |
| 11 Month Change | -12.81% |
| 3 Month Change | -10.47% |
| 1 Year Change | 8.87% |
| 33 Year Change | -23.78% |
| 5 Year Change | 22.88% |
| Change since IPO | 1,142.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| NZM2 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -8.1% | -3.2% | -1.5% |
| 1Y | 8.9% | -1.1% | 7.9% |
Return vs Industry: NZM2 exceeded the German Chemicals industry which returned -1% over the past year.
Return vs Market: NZM2 matched the German Market which returned 8.3% over the past year.
Price Volatility
| NZM2 volatility | |
|---|---|
| NZM2 Average Weekly Movement | 2.6% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NZM2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: NZM2's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 10,452 | Ester Baiget | www.novonesis.com |
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Novonesis A/S Fundamentals Summary
| NZM2 fundamental statistics | |
|---|---|
| Market cap | €24.30b |
| Earnings (TTM) | €282.79m |
| Revenue (TTM) | €3.04b |
85.9x
P/E Ratio8.0x
P/S RatioIs NZM2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NZM2 income statement (TTM) | |
|---|---|
| Revenue | €3.04b |
| Cost of Revenue | €1.62b |
| Gross Profit | €1.42b |
| Other Expenses | €1.14b |
| Earnings | €282.79m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 46.66% |
| Net Profit Margin | 9.29% |
| Debt/Equity Ratio | 18.1% |
How did NZM2 perform over the long term?
See historical performance and comparison